UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - jihane+benhammou
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
2018-199 Identification of OLMAINC as a Biomarker for NAFLD, NASH, Metabolic Syndrome, and Hepatic Fibrosis
Identification Of OLMAINC as a Biomarker for NAFLD, NASH, Metabolic Syndrome, Hepatic FibrosisSUMMARYUCLA researchers in the Departments of Medicine and Human Genetics have identified a sequence of long, non-coding RNA that plays a role in the regulation of intracellular lipogenesis and holds potential for diagnosing and treating metabolic diseases,...
Published: 7/19/2023
|
Inventor(s):
Jihane Benhammou
,
Paivi Pajukanta
,
Joseph Pisegna
Keywords(s):
Diagnostic Markers & Platforms
,
Metabolic Diseases
,
Therapeutics & Vaccines
Category(s):
Diagnostic Markers
,
Therapeutics
,
Therapeutics > Metabolism And Endocrinology